Vahidy, F. S., Haque, M. E., Rahbar, M. H., Zhu, H., Rowan, P., Aisiku, I. P., . . . Savitz, S. I. (2019). Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial. Stem cells (Dayton, Ohio), 37(11), 1481-1491. https://doi.org/10.1002/stem.3080
Citace podle Chicago (17th ed.)Vahidy, Farhaan S., et al. "Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial." Stem Cells (Dayton, Ohio) 37, no. 11 (2019): 1481-1491. https://doi.org/10.1002/stem.3080.
Citace podle MLA (9th ed.)Vahidy, Farhaan S., et al. "Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial." Stem Cells (Dayton, Ohio), vol. 37, no. 11, 2019, pp. 1481-1491, https://doi.org/10.1002/stem.3080.